Point72 Asset Management
PVLA

Point72 Asset Management’s Palvella Therapeutics PVLA Stock Holding History

Point72 Asset Management’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11M Buy
88,160
+10,863
+14% +$1.13M 0.02% 1175
2025
Q4 		$8.09M Sell
77,297
-240,012
-76% -$20.5M 0.01% 1484
2025
Q3 		$19.9M Buy
+317,309
New +$14.2M 0.04% 550
2021
Q3 		– Sell
-12,500
Closed -$3.83M – 1302
2021
Q2 		$3.83M Buy
+12,500
New +$2.74M 0.02% 653
2019
Q3 		– Sell
-4,271
Closed -$1.61M – 1555
2019
Q2 		$1.61M Hold
4,271
– – 0.01% 688
2019
Q1 		$1.15M Hold
4,271
– – 0.01% 793
2018
Q4 		$909K Buy
+4,271
New +$1.32M 0.01% 816

Other funds holding PVLA

SCM
Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return